Pharma		30.01%
Services		23.55%
Medtech		12.18%
Diagnostics		11.98%
Biotech		3.37%
Generics		3.31%

Europe		49.75%
EM Asia		12.29%
Nordamerika		6.55%
EM Rest World		5.79%
Asien		5.46%
EM Europe		4.58%